Central Garden & Pet (CENT) is scheduled to release its fourth-quarter financial results after Wednesday's market close, with Wall Street anticipating a year-over-year revenue decline. The report comes as the broader household products sector shows investor optimism.
As Lucky Strike (NYSE:LUCK) prepares to release its Q4 results, investors are weighing its recent outperformance against a history of revenue misses and a slumping stock price. Here's the breakdown ahead of the bell.
The fast-food giant prepares to release its quarterly results as analysts project moderated growth and investors weigh recent performance against sector peers.
CDW Corporation is set to report its fourth-quarter earnings before the market opens on Wednesday. Analysts project modest revenue growth, but the company's recent performance and broader sector trends suggest a cautious outlook.
Across India's villages and small towns, a new generation of workers is logging on after sunset to label the data that trains the world's most advanced AI systems. This quiet workforce, many of them women and first-generation graduates, is finding economic opportunity while reshaping global tech's supply chain.
The Timken Company (NYSE: TKR) is scheduled to release its fourth-quarter financial results before the market opens on Wednesday. Investors will be watching to see if the bearings and power transmission specialist can continue its track record of surpassing Wall Street's forecasts amidst a mixed landscape for industrial machinery firms.
Healthcare distribution giant Cencora (COR) is set to report quarterly earnings before Wednesday's market open. Analysts project steady revenue growth, but investor focus will be on guidance amid mixed performances from sector peers.
Despite stellar fundamentals and a dominant market position, Mastercard's premium valuation is prompting a debate among investors. While bulls champion its profitability and growth, skeptics warn of overextension, suggesting a pullback may offer a more attractive entry point.
After Abbott Laboratories' stock plunged nearly 10% on disappointing revenue, CEO Robert B. Ford made a significant personal investment, purchasing $2 million in company shares. This move, seen as a strong signal of insider confidence, highlights a clash between short-term market jitters and long-term corporate strategy.
New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
Universal Technical Institute (NYSE: UTI) is scheduled to release its fourth-quarter earnings after Wednesday's market close. Investors are watching for signs of sustained growth in the vocational education sector as economic conditions shift.
Brazil's state-controlled oil giant Petrobras is trading at deep value multiples, offering investors a covered dividend yield near 10%. Analysts argue its disciplined payout and exposure to a tightening global oil market create a rare mix of income and asymmetric upside.
Global equities and commodities staged a broad recovery on Tuesday, shaking off a pan-Asian rout triggered by a hawkish Fed nominee and geopolitical jitters. The rebound was anchored by surprisingly strong US manufacturing figures, offering a respite to bruised investors.
A Los Angeles family is mourning the devastating loss of Regan Cole-Graham, 36, and her unborn daughter after a cycling accident. The mother of two was riding with her family when she was struck by a vehicle.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
Despite near-term pressures in China and IP markets, Synopsys's robust recurring revenue, strategic Ansys acquisition, and pivotal role in AI-driven chip design are building a compelling case for investor confidence, backed by strong margin expansion and cash flow projections.
Specialist asset manager Cohen & Steers (NYSE: CNS) is attracting bullish attention as its focus on real assets aligns with a shifting monetary policy landscape. After a prolonged period of outflows, the firm is seeing renewed investor interest.
Cronos Group's stock has rallied on renewed optimism for U.S. cannabis reform. We examine the regulatory shift, strategic positioning, and long-term potential driving investor sentiment.
With its trust fund projected to be depleted by 2032, the Social Security program faces a pivotal moment. Congress must enact reforms within the next seven years to prevent automatic, across-the-board benefit reductions for millions of Americans.
Investor and TV personality Kevin O'Leary has thrown his weight behind a proposed national child investment account policy, framing it as a bipartisan solution to America's widespread financial illiteracy and a foundational tool for building generational wealth.
